Prosecution Insights
Last updated: April 19, 2026

Nanomedi Pharm Co. Ltd.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18104436 TUMOR TARGETED DIAGNOSTIC IMAGING AGENT FOR DIAGNOSTIC BIOPSY, OR INTRAOPERATIVE TUMOR IDENTIFICATION OR MARGIN ASSESSMENT USING NEAR-INFRARED FLUORESCENCE (NIRF) IMAGING MEJIAS, SAMANTHA LEE 1618 Final Rejection Feb 01, 2023

Managing Nanomedi Pharm Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month